Market Overview:
The global bioanalytical testing services market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for bioanalytical testing services from biopharmaceutical companies, CDMO/CMOs, and CROs. Additionally, the growing prevalence of chronic diseases is also contributing to the growth of this market. The global bioanalytical testing services market can be segmented on the basis of type and region. On the basis of type, the market can be divided into small molecules and large molecules. The small molecules segment is expected to account for a larger share of the global bioanalytical testing services market than the large molecules segment duringthe forecast period owingto its high adoption by biopharmaceutical companies and CROs.
Product Definition:
Bioanalytical testing services are used to analyze the biological effects of drugs and other xenobiotics. The importance of bioanalytical testing services is that they can help to determine the toxicity and efficacy of a drug or other xenobiotic.
Small Molecules:
Small molecules are the chemical compounds that have a molecular weight less than 1000. They can be naturally occurring or synthetic (man-made). The most commonly used small molecule in the world is oxygen which has a molecular weight of 16.0 grams per mole. Small molecules account for 75% of all chemicals manufactured worldwide and 50% of all chemicals used in industry and commerce globally.
Large Molecules:
Large molecules are organic or inorganic compounds with a molecular weight greater than 1000. The term “large” is used to differentiate them from small molecules which have a molecular weight of 100 and below. Large molecules can be further classified as peptides, proteins, oligosaccharides (oligosaccharide is a short-chain carbohydrates), nucleic acids (DNA & RNA), glycoproteins, hormones, and others.
Application Insights:
The global market is segmented by application into biopharmaceutical companies, clinical research organizations (CROs), and drug manufacturing companies/clinical management organizations (DMCs/CMOs). The biopharmaceutical companies segment dominated the market in 2017. This is attributed to the rising number of novel drug applications being filed with regulatory authorities. Moreover, an increasing number of partnerships among key players further strengthen their position in this industry. For instance, in April 2018 collaboration among Amgen Inc., Pfizer Inc., and Teva Pharmaceuticals USA was announced to develop a next-generation sequencing assay for cancer immunotherapy development.
Clinical Research Organizations (CROs) are anticipated to witness lucrative growth over the forecast period owing to an increase in government funding for medical research coupled with growing emphasis on improving patient safety through bioanalytical studies performed by CROs at Clinical Centers of Excellence worldwide.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical manufacturing entities and CROs in this region has fueled the demand for bioanalytical testing services over the past few years. Moreover, growing investments by governments to support R&D activities are expected to contribute towards market growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing outsourcing activities by companies based in North America and Europe coupled with government initiatives encouraging domestic drug development programs. In addition, rising healthcare expenditure levels are also likely to spur regional market expansion during 2018-2030 periods.
Growth Factors:
- Increasing demand for bioanalytical testing services from the pharmaceutical and biotechnology industries to support drug development and regulatory compliance.
- The increasing use of bioanalytical testing services for personalized medicine and companion diagnostics.
- The growing demand for bioanalytical testing services in the field of food safety and environmental monitoring.
- The increasing use of bioanalytical testing services in academic research laboratories and contract research organizations (CROs).
- Advances in analytical technologies that are enabling more complex and sensitive tests to be performed, which is driving the demand for bioanalytical testing services
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioanalytical Testing Services Market Research Report
By Type
Small Molecules, Large Molecules
By Application
Biopharmaceutical Companies, CDMO/CMO, CRO
By Companies
PPD, SGS, Charles River Laboratories, ICON plc, LabCorp (Covance), Toxikon, Intertek, BioReliance, Bioclin Research Laboratories, Eurofins, PRA Health Sciences, BioOutsource, Particle Sciences, WuXi PharmaTech (Cayman)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Bioanalytical Testing Services Market Report Segments:
The global Bioanalytical Testing Services market is segmented on the basis of:
Types
Small Molecules, Large Molecules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, CDMO/CMO, CRO
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PPD
- SGS
- Charles River Laboratories
- ICON plc
- LabCorp (Covance)
- Toxikon
- Intertek
- BioReliance
- Bioclin Research Laboratories
- Eurofins
- PRA Health Sciences
- BioOutsource
- Particle Sciences
- WuXi PharmaTech (Cayman)
Highlights of The Bioanalytical Testing Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecules
- Large Molecules
- By Application:
- Biopharmaceutical Companies
- CDMO/CMO
- CRO
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioanalytical Testing Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioanalytical testing services are a type of laboratory service that provides analysis of biological specimens for the purpose of detecting, diagnosing, and treating diseases.
Some of the major players in the bioanalytical testing services market are PPD, SGS, Charles River Laboratories, ICON plc, LabCorp (Covance), Toxikon, Intertek, BioReliance, Bioclin Research Laboratories, Eurofins, PRA Health Sciences, BioOutsource, Particle Sciences, WuXi PharmaTech (Cayman).
The bioanalytical testing services market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioanalytical Testing Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioanalytical Testing Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioanalytical Testing Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioanalytical Testing Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioanalytical Testing Services Market Size & Forecast, 2018-2028
4.5.1 Bioanalytical Testing Services Market Size and Y-o-Y Growth
4.5.2 Bioanalytical Testing Services Market Absolute $ Opportunity
Chapter 5 Global Bioanalytical Testing Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bioanalytical Testing Services Market Size Forecast by Type
5.2.1 Small Molecules
5.2.2 Large Molecules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bioanalytical Testing Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bioanalytical Testing Services Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 CDMO/CMO
6.2.3 CRO
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioanalytical Testing Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioanalytical Testing Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bioanalytical Testing Services Analysis and Forecast
9.1 Introduction
9.2 North America Bioanalytical Testing Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bioanalytical Testing Services Market Size Forecast by Type
9.6.1 Small Molecules
9.6.2 Large Molecules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bioanalytical Testing Services Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 CDMO/CMO
9.10.3 CRO
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bioanalytical Testing Services Analysis and Forecast
10.1 Introduction
10.2 Europe Bioanalytical Testing Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bioanalytical Testing Services Market Size Forecast by Type
10.6.1 Small Molecules
10.6.2 Large Molecules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bioanalytical Testing Services Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 CDMO/CMO
10.10.3 CRO
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bioanalytical Testing Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bioanalytical Testing Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bioanalytical Testing Services Market Size Forecast by Type
11.6.1 Small Molecules
11.6.2 Large Molecules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bioanalytical Testing Services Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 CDMO/CMO
11.10.3 CRO
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bioanalytical Testing Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Bioanalytical Testing Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bioanalytical Testing Services Market Size Forecast by Type
12.6.1 Small Molecules
12.6.2 Large Molecules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bioanalytical Testing Services Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 CDMO/CMO
12.10.3 CRO
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bioanalytical Testing Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bioanalytical Testing Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bioanalytical Testing Services Market Size Forecast by Type
13.6.1 Small Molecules
13.6.2 Large Molecules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bioanalytical Testing Services Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 CDMO/CMO
13.10.3 CRO
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioanalytical Testing Services Market: Competitive Dashboard
14.2 Global Bioanalytical Testing Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PPD
14.3.2 SGS
14.3.3 Charles River Laboratories
14.3.4 ICON plc
14.3.5 LabCorp (Covance)
14.3.6 Toxikon
14.3.7 Intertek
14.3.8 BioReliance
14.3.9 Bioclin Research Laboratories
14.3.10 Eurofins
14.3.11 PRA Health Sciences
14.3.12 BioOutsource
14.3.13 Particle Sciences
14.3.14 WuXi PharmaTech (Cayman)
